Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further Treatment
Clinical trial NCT00683306 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00683306
- Sponsor
- AstraZeneca
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.